1. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program https://seer.cancer.gov/ . Accessed 18 Jan 2017.
2. National Cancer Institute. State Cancer Profiles. https://statecancerprofiles.cancer.gov/index.html . Accessed 10 Mar 2017.
3. Centers for Medicare & Medicaid Services. Institute of Medicine (IOM) Geographic Variation Data Request: A Methodological Overview. 2012. http://www.nationalacademies.org/hmd/Activities/HealthServices/GeographicVariation/~/media/Files/Activity%20Files/HealthServices/GeographicVariation/CMSfiles/Dec-2012/Geographic%20Variation%20Methods%20Paper%20Dec%202012%20Update.pdf .
4. Devarakonda S, Morgensztern D, Govindan R. Genomic alterations in lung adenocarcinoma. Lancet Oncol. 2015;16(7):e342–51.
5. National Comprehensive Cancer Network. The NCCN Clinical Practice Guidelines in Oncology for Non-Small Cell Lung Cancer version 5.2017. 2017; http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf . Accessed 12 Apr 2017.